Bristol Myers Squibb (BMS) and AstraZeneca are reportedly considering a merger that could create a company valued at nearly $400 billion.
The companies are among the largest pharmaceutical employers in...
‘After Labor Day weekend last year the bottom fell out of the market. says Peter Doolan, second generation owner of the 70-year-old Pennington-based real...